Inhalation solutions - which one are allowed to be mixed? Physico-chemical compatibility of drug solutions in nebulizers

Journal of Cystic Fibrosis

Volumn 5, Issue 4, 2006, Pages 205-213

  Kamin, Wolfgang ^a   Schwabe, Astrid ^a   Krämer, Irene ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Compatibility; Inhalation solutions; Nebulizer; Review

Indexed keywords

ACETEIN; ACETYLCYSTEINE; ADRENERGIC RECEPTOR STIMULATING AGENT; ALUPENT INHALATION SOLUTION; AMBROXOL; ANTIBIOTIC AGENT; ATROVENT INHALATION SOLUTION; ATROVENT LS; BERODUAL LS; BETAMETHASONE; BRONCHODILATING AGENT; BUDESONIDE; COLISTIN; COLISTIN ZUR INHALATION; COLY MYCIN PARENTERAL; CROMOGLYCATE DISODIUM; DORNASE ALFA; FENOTEROL; FENOTEROL PLUS IPRATROPIUM BROMIDE; IPRATROPIUM BROMIDE; IPRATROPIUM BROMIDE PLUS SALBUTAMOL SULFATE; LEVALBUTEROL; LYSOMUCIL; MUCOSOLVAN INHALATION SOLUTION; NETILMICIN; NETROMICINE; ORCIPRENALINE; PROMIXIN POWDER; SALBUTAMOL; SODIUM CHLORIDE; SULTANOL FERTIGINHALAT; TERBUTALINE; TOBRAMYCIN; TOBRAMYCIN SULFATE;

CHRONIC RESPIRATORY TRACT DISEASE; DRUG FORMULATION; DRUG INFORMATION; DRUG MIXTURE; DRUG SOLUTION; DRUG STABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTERVIEW; MEDICAL LITERATURE; NEBULIZATION; NEBULIZER; PHYSICAL CHEMISTRY; PRESCRIPTION; REVIEW; TELEPHONE;

ACETYLCYSTEINE; ADMINISTRATION, INHALATION; ALBUTEROL; ANTI-ASTHMATIC AGENTS; ANTI-BACTERIAL AGENTS; ASTHMA; BRONCHODILATOR AGENTS; BUDESONIDE; COLISTIN; CROMOLYN SODIUM; CYSTIC FIBROSIS; DEOXYRIBONUCLEASE I; DRUG THERAPY, COMBINATION; EXPECTORANTS; HUMANS; IPRATROPIUM; NEBULIZERS AND VAPORIZERS; RESPIRATORY THERAPY; TOBRAMYCIN;

EID: 34347323745     PISSN: 15691993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcf.2006.03.007     Document Type: Review

References (30)

1. Boe J., Dennis J.H., O'Driscoll B.R., Bauer T.T., Carone M., Dautzenberg B., et al. For the society task force on the use of nebulizers. European Respiratory Society guidelines on the use of nebulizers. Eur Respir J 18 (2001) 228-242
2. American Society of Health System Pharmacists Inc. International pharmaceutical abstracts (2003), Silver Platter International, New York I31
3. In: Hutchinson T.A., and Shahan D.R. (Eds). DRUGDEX® system (2004), Micromedex, Greenwood Village, CO 121
4. American Society of Health-System Pharmacists Inc. AHFS drug information 2003 (2003), ASHP, Bethesda
5. Trissel L.A. Handbook on injectable drugs. 12th Ed. (2003), ASHP
6. Gooch M.D. Stability of albuterol and tobramycin when mixed for aerosol administration. Respir Care 36 (1991) 1387-1390
7. Nagtegaal J.E., De Jong A., De Waard W.J., and Van der Meer Y.G. Formulation and shelf life of two solutions for inhalation. Ziekenhuis farmacie 13 (1997) 23-29
8. Jacobson G.A., and Peterson G.M. Stability of ipratropium bromide and salbutamol nebuliser admixtures. Int J Pharm Pract 3 (1995) 169-173
9. Hood JC, White TS. Stability of selected antibiotics solutions with albuterol and ipratropium inhalation solutions in the treatment of pulmonary infections. ASHP-Midyear-Clinical-Meeting 33 (1998) P-43E. Personal communication.
10. Roberts G.W., Badcock N.R., and Jarvinen A.O. Cystic fibrosis inhalation therapy: stability of a combined salbutamol/colistin solution. Aust J Hosp Pharm 22 (1992) 378-380
11. Lesko L.J., and Miller A.K. Physical chemical compatibility of cromolyn sodium inhalation solution - bronchodilator inhalant solution admixtures. Ann Allergy 53 (1984) 236-238
12. Iacono M., Johnson G.J., and Bury R.W. An investigation of the compatibility of ipratropium and sodium cromoglycate nebuliser solutions. Aust J Hosp Pharm 17 (1987) 158-161
13. Turner M. Compatibility of nebuliser solutions (letter). Aust J Hosp Pharm 17 (1987) 241-242
14. Emm T., Metcalf J.E., Lesko L.J., and Chai M.F. Update on the physical-chemical compatibility of cromolyn sodium inhalation solution: bronchodilator inhalant solution admixtures. Ann Allergy 66 (1991) 185-189
15. Smaldone G.C., McKenzie J., Cruz Rivera M., and Hoag J. Budesonide inhalation suspension is chemically compatible with other nebulizing formulations (Abstract). Chest 118 (2000) 98
16. McKenzie J.E., and Cruz Rivera M. Compatibility of budesonide inhalation suspension with four nebulizing solutions. Ann Pharmacother 38 6 (2004) 967-972
17. Grönberg S, Magnusson P, Bladh N. Chemical compatibility of budesonide inhalation suspension (Pulmicort™) with other nebulization products (Abstract). Meeting of the American Thoracic Society 2001. Personal communication.
18. Tzung-Yiet L., Chi-Ming C., Chun-Nin L., Yi-Chun C., and Hsiang-Yin C. Compatibility and osmolality of inhaled N-acetylcysteine nebulizing solution with fenoterol and ipratropium. Am J Health-Syst Pharm 62 (2005) 828-833
19. Rieutord A., Arnaud P., Dauphin J.F., and Brion F. Stability and compatibility of an aerosol mixture including N-acetylcysteine, netilmicin and betamethasone. Int J Pharm 190 (1999) 103-107
20. Joseph J.C. Compatibility of inhalation solution admixtures. Ann Pharmacother 31 (1997) 487-489
21. Roberts G.W., and Rossi S.O.P. Compatibility of nebuliser solutions. Aust J Hosp Pharm 23 (1993) 35-37
22. Allen L.V. Combination solutions for bronchospasm. US-Pharmacist 24 (1999) 82-83
23. Harriman A.M., Purcell N., Fleming S., and Daly M.J. Can we mix nebuliser solutions?. Pharm Pract 6 (1996) 347-348
24. Owsley H.D., and Rusho W.J. Compatibility of common respiratory therapy drug combinations. Int J Pharm Compd 1 (1997) 121-122
25. United States Pharmacopeial Convention, Inc. The United States pharmacopeia. 24th Ed. (2000), United States Pharmacopeial Convention, Inc., Rockville
26. Pharmacopoeia European basic edition. 4th Ed. Deutscher Apotheker Verlag, Stuttgart, Govi-Verlag-Pharmazeutischer Verlag, Eschborn; 2002.
27. Pharmacopoeia European 4th supplement. 4th Ed. Deutscher Apotheker Verlag, Stuttgart, Govi-Verlag-Pharmazeutischer Verlag, Eschborn; 2003
28. Clay M.M., Pavia D., Newman S.P., Lennard-Jones T., and Clarke S.W. Assessment of jet nebulisers for lung aerosol therapy. Lancet 2 (1983) 592-594
29. McKenzie J., Gronberg S., Cruz M., and Rivera J. Budesonide inhalation suspension can be nebulized with solutions containing albuterol sulphate (Poster). Chest 122 (2002) 183S [Suppl.]
30. Smaldone GC, McKenzie J, Cruz Rivera M. Effect of nebulizer volume on drug delivery: budesonide inhalation suspension. Meeting of the American Thoracic Society, 2000. Personal communication.